Novo Nordisk
NVO
#19
Rank
HK$3.721 T
Marketcap
HK$819.75
Share price
-1.49%
Change (1 day)
5.87%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2024 : HK$87.31 Billion

According to Novo Nordisk's latest financial reports the company has HK$87.31 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$34.96 B31.83%
2022-12-31HK$26.52 B27.78%
2021-12-31HK$20.75 B26.98%
2020-12-31HK$16.34 B-9.54%
2019-12-31HK$18.07 B-3.69%
2018-12-31HK$18.76 B-20.98%
2017-12-31HK$23.74 B4.48%
2016-12-31HK$22.72 B-2.23%
2015-12-31HK$23.24 B15.36%
2014-12-31HK$20.14 B-3%
2013-12-31HK$20.77 B-6.15%
2012-12-31HK$22.13 B-6.53%
2011-12-31HK$23.68 B6.23%
2010-12-31HK$22.29 B16.36%
2009-12-31HK$19.15 B29.63%
2008-12-31HK$14.77 B31.16%
2007-12-31HK$11.26 B60.13%
2006-12-31HK$7.03 B14.23%
2005-12-31HK$6.16 B9.14%
2004-12-31HK$5.64 B38.96%
2003-12-31HK$4.06 B108.05%
2002-12-31HK$1.95 B-42.89%
2001-12-31HK$3.41 B139.03%
2000-12-31HK$1.43 B0.69%
1999-12-31HK$1.42 B60.16%
1998-12-31HK$0.88 B-29.12%
1997-12-31HK$1.25 B23.12%
1996-12-31HK$1.01 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$77.46 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.38 B-68.63%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$62.99 B-27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$56.69 B-35.06%๐Ÿ‡ซ๐Ÿ‡ท France